Seraph

Altavair Appoints New Head of Technical

Retrieved on: 
Monday, January 29, 2024

Altavair Limited (“Altavair”), a global commercial aviation asset servicer, announced today that Stephen Coyle has been appointed as Head of Technical.

Key Points: 
  • Altavair Limited (“Altavair”), a global commercial aviation asset servicer, announced today that Stephen Coyle has been appointed as Head of Technical.
  • Mr. Coyle succeeds Joe Gleeson who is stepping down from the role after 14 years.
  • Mr. Gleeson will continue with Altavair as a Senior Technical Director.
  • “We are also very grateful to Joe for his dedication to the company and many significant achievements over the years, and delighted that he will continue to support our efforts in his new capacity.”
    Before joining Altavair as Senior Technical Director in March 2023, Mr. Coyle held senior leadership positions with Seraph Aviation Management Limited, as Chief Technical Officer, and Aercap, as Head of Technical for EMEA and APAC.

"SERAPH: In the Darkness" Confirms Innovative Blockchain Gaming Economic Models at Conclusion of Chaos Legacy Test

Retrieved on: 
Thursday, January 4, 2024

The Chaos Legacy Test focused on validating the practical economic model of the game.

Key Points: 
  • The Chaos Legacy Test focused on validating the practical economic model of the game.
  • During the testing period, the development team maintained a rapid update frequency, continuously fixing game bugs and promptly adjusting the economic model and gameplay issues.
  • North America and Europe also gradually rose in the latter half of the test, reflecting the global popularity of SERAPH.
  • These initiatives aim to meet the needs of global players and evolve the economic model, bridging the gap between Web3 and traditional gamers.

'SERAPH: In The Darkness' Seeks to Enhance ARPG Experience by Launching on Arbitrum

Retrieved on: 
Wednesday, November 29, 2023

SEOUL, South Korea, Nov. 29, 2023 /PRNewswire/ --  Seraph Studio, an international games studio backed by Korean gaming giant Actoz Soft, today announced the launch of SERAPH: In The Darkness, an action role-playing game (ARPG), on Arbitrum One. The unique ARPG experience brought to the table by SERAPH is poised to bring a new gameplay experience to the Arbitrum ecosystem and provide games with an immersive, interactive gaming environment that bridges the gap between traditional gaming and blockchain technology.

Key Points: 
  • SEOUL, South Korea, Nov. 29, 2023 /PRNewswire/ --  Seraph Studio, an international games studio backed by Korean gaming giant Actoz Soft, today announced the launch of SERAPH: In The Darkness, an action role-playing game (ARPG), on Arbitrum One.
  • The unique ARPG experience brought to the table by SERAPH is poised to bring a new gameplay experience to the Arbitrum ecosystem and provide games with an immersive, interactive gaming environment that bridges the gap between traditional gaming and blockchain technology.
  • Arbitrum, with its advanced, game-friendly tech stack via Arbitrum One, and its growing games ecosystem, makes leading Layer 2 blockchain a natural selection to launch SERAPH which has already seen an incredible response from the blockchain gaming community.
  • Alongside the launch, Seraph Studio will continue to roll out exclusive campaigns and experiences for SERAPH, designed to captivate both web2 and web3 gamers.

Kodansha Launches New Series KATANA Beast Simultaneously in Japan & U.S. and More Simulpub Titles on K MANGA

Retrieved on: 
Tuesday, October 31, 2023

TOKYO, Oct. 31, 2023 /PRNewswire/ -- Kodansha Ltd. is pleased to announce that it will launch the new series KATANA Beast by Akimine Kamijyo simultaneously in Japan and the United States at the same time. The English version of KATANA Beast will be available on the K MANGA service as a simulpub title starting November 1st 12:00AM JST (October 31st 8:00AM PDT). Kodansha plans to add 74 titles to K MANGA before the end of the year, with more information to be announced. New simulpub titles will include Versus (One-Punch Man creator ONE, bose, and Kyoutarou Azuma), and Tank Chair (Manabu Yashiro).  The K MANGA service is currently exclusively available in the United States.

Key Points: 
  • TOKYO, Oct. 31, 2023 /PRNewswire/ -- Kodansha Ltd. is pleased to announce that it will launch the new series KATANA Beast by Akimine Kamijyo simultaneously in Japan and the United States at the same time.
  • The English version of KATANA Beast will be available on the K MANGA service as a simulpub title starting November 1st 12:00AM JST (October 31st 8:00AM PDT).
  • Kodansha plans to add 74 titles to K MANGA before the end of the year, with more information to be announced.
  • New simulpub titles will include Versus (One-Punch Man creator ONE, bose, and Kyoutarou Azuma), and Tank Chair (Manabu Yashiro).

ExThera Medical Awarded U.S. Federal Supply Schedule Contract for Seraph 100 Blood Filter

Retrieved on: 
Tuesday, October 10, 2023

ExThera Medical Corporation has been awarded a 5-year U.S. Department of Veterans Affairs (VA) Federal Supply Schedule (FSS) contract, which allows ExThera to pursue contracts with federal healthcare organizations including the U.S. Department of Veteran Affairs, U.S. Federal Prison System, Indian Reservations, and the Department of Defense.

Key Points: 
  • ExThera Medical Corporation has been awarded a 5-year U.S. Department of Veterans Affairs (VA) Federal Supply Schedule (FSS) contract, which allows ExThera to pursue contracts with federal healthcare organizations including the U.S. Department of Veteran Affairs, U.S. Federal Prison System, Indian Reservations, and the Department of Defense.
  • The contract grants streamlined access to the company’s Seraph® 100 MicroBind® Affinity Blood Filter.
  • Military and VA clinicians have been enthusiastic users of Seraph 100 for the treatment of COVID-19.
  • “ExThera is proud to be contracted by the Federal Supply Schedule, working closely with federal agencies to expand access to the Seraph 100.

FDA Grants ExThera Multiple Breakthrough Device Designations for its Seraph® 100 Filter

Retrieved on: 
Tuesday, October 3, 2023

ExThera Medical Corporation, a healthcare company developing and manufacturing extracorporeal pathogen technologies, announces that it has received multiple Breakthrough Device Designations from the U.S. Food and Drug Administration (FDA), for its Seraph® 100 Microbind® Affinity Blood Filter (Seraph 100).

Key Points: 
  • ExThera Medical Corporation, a healthcare company developing and manufacturing extracorporeal pathogen technologies, announces that it has received multiple Breakthrough Device Designations from the U.S. Food and Drug Administration (FDA), for its Seraph® 100 Microbind® Affinity Blood Filter (Seraph 100).
  • The Seraph 100 is a patented blood filter containing a biomimetic surface, similar to that found in the human circulatory system that removes pathogens that could otherwise overwhelm a patient; a common source of severe/critical illness.
  • “In addition, a Breakthrough Device Designation allows for immediate coverage through Centers for Medicare and Medicaid Services (CMS) via New Technology Add-On Payment (NTAP).
  • Breakthrough Device Designations are an important addition to this ongoing activity, along with future pandemic preparedness.

Award-Winning Horror Novelist Brian James Gage Unveils His Debut AI-Assisted Graphic Novel Series: The Nosferatu Conspiracy

Retrieved on: 
Tuesday, October 3, 2023

LOS ANGELES, Oct. 3, 2023 /PRNewswire-PRWeb/ -- Acclaimed novelist Brian James Gage launches his groundbreaking AI-assisted graphic novel series, The Nosferatu Conspiracy. This graphic serial is based on his trilogy of horror novels of the same name, which have garnered critical acclaim and won multiple awards. The trilogy is now reborn as an epic graphic novel serialization that promises to captivate readers with its rich storytelling and innovative AI-generated artwork.

Key Points: 
  • Acclaimed novelist Brian James Gage launches his groundbreaking AI-assisted graphic novel series, The Nosferatu Conspiracy.
  • LOS ANGELES, Oct. 3, 2023 /PRNewswire-PRWeb/ -- Acclaimed novelist Brian James Gage launches his groundbreaking AI-assisted graphic novel series, The Nosferatu Conspiracy.
  • Brian James Gage is reimagining his haunting trilogy into an ambitious graphic novel serialization that will span an estimated thirty volumes upon completion.
  • Early Praise for The Nosferatu Conspiracy Volume One, Lady of the Loch:
    "...Bewitching...a visually compelling graphic debut that's beautifully executed..."—Book Viral Reviews, Golden Quill Spotlight.

FLORIDA SOUTHERN COLLEGE'S 2023-24 FESTIVAL OF FINE ARTS: A CELEBRATION OF CREATIVITY AND CULTURE IN LAKELAND

Retrieved on: 
Friday, September 15, 2023

LAKELAND, Fla., Sept. 15, 2023 /PRNewswire/ -- Florida Southern College's Festival of Fine Arts, a longstanding pillar of artistic expression in the Central Florida community, is set to captivate audiences again with its exceptional lineup for the 2023-24 season.

Key Points: 
  • LAKELAND, Fla., Sept. 15, 2023 /PRNewswire/ -- Florida Southern College's Festival of Fine Arts, a longstanding pillar of artistic expression in the Central Florida community, is set to captivate audiences again with its exceptional lineup for the 2023-24 season.
  • "We invite everyone to join us at the Festival of Fine Arts this season," says President Kerr.
  • "Your presence and support are instrumental in nurturing creativity and ensuring that the spirit of art thrives in our community.
  • For a complete list of events and to buy tickets, visit the Festival of Fine Arts at flsouthern.edu/ffa.

ExThera Medical Receives Certification for Medical Device Single Audit Program (MDSAP) and Recertification for International Organization for Standardization for Medical Devices (ISO 13485)

Retrieved on: 
Tuesday, August 15, 2023

ExThera Medical Corporation announces it has received simultaneous certification per Medical Device Single Audit Program (MDSAP) and International Organization for Standardization (ISO 13485) requirements.

Key Points: 
  • ExThera Medical Corporation announces it has received simultaneous certification per Medical Device Single Audit Program (MDSAP) and International Organization for Standardization (ISO 13485) requirements.
  • MDSAP certification confirms comprehensive achievement of regulatory audit requirements and compliance standards for medical device manufacturers looking to sell products within the United States (FDA), Canada (HC), Japan (MHLW), Australia (TGA), and Brazil (ANVISA).
  • MDSAP certification has the added benefit of potentially expediting the timetable to commercialization within these participating geographies.
  • The internationally recognized ISO 13485 certification further confirms achievement of medical device manufacturer quality standards requirements necessary for global market entry.

ExThera Medical in Growth Mode after FDA Approval of Investigational Device Exemption

Retrieved on: 
Wednesday, July 26, 2023

(h)., NAE, the CEO & a founder of ExThera Medical.

Key Points: 
  • (h)., NAE, the CEO & a founder of ExThera Medical.
  • Additionally, “Michael brings additional sophistication necessary for large-scale transactions needed for growth and maturity of the company,” said Erin Borger, Director & ExThera Board Member.
  • The advising team for the new program within ExThera Medical includes:
    Jay Wohlgemuth, M.D., former CMO of highly successful Quest Diagnostics, responsible for R&D, Medical Affairs, and Laboratory Quality.
  • Earlier this month ExThera announced FDA approval of a recently submitted Investigational New Device (IDE) application for its OncoBind™ Procedure.